Document is current
Any future updates will be listed below
-
Authors
Penton, Hannah http://orcid.org/0000-0001-9492-7875
Jayade, Sayeli
Selveindran, Santhani
Heisen, Marieke
Piketty, Christophe
Ulianov, Liliana
Jabbar-Lopez, Zarif K.
Silverberg, Jonathan I.
Puelles, Jorge
-
Funding
Funding for this research was provided by:
Galderma
- License Information
-
More Information
Article History
Received: 1 August 2023
Accepted: 11 September 2023
First Online: 25 September 2023
Declarations
:
: Christophe Piketty, Liliana Ulianov, Zarif K. Jabbar-Lopez and Jorge Puelles are employees of Galderma, which funded this research. Hannah Penton, Sayeli Jayade, Santhani Selveindran and Marieke Heisen are employees of OPEN Health, which received consulting fees from Galderma in connection with this study. Jonathan I. Silverberg has received honoraria as a consultant and/or advisory board member for AbbVie, Alamar, Aldena, Amgen, AObiome, Arcutis, Arena, Asana, Aslan, BioMX, Biosion, Bodewell, Boehringer Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Leo Pharma, Menlo, Novartis, Optum, Pfizer, RAPT, Regeneron, Sanofi-Genzyme, Shaperon, and Union, and as a speaker for AbbVie, Eli Lilly, Leo Pharma, Pfizer, Regeneron, and Sanofi-Genzyme; his institution received grants from Galderma, Incyte, and Pfizer.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
